Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Proteins & Peptides
Filter     Order     Display # 
Date Item Title
08 Jul 2008 Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
08 Jul 2008 Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
06 Jul 2008 Sentek Announces Termination of Invicorp(R) Licensse Agreement With Ardana Bioscience Limited
06 Jul 2008 Advitech announces positive clinical and pre-clinical results
03 Jul 2008 RegeneRx Completes Enrollment and Dosing of Phase IA Safety Trial for Potential Heart Drug
02 Jul 2008 Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen
02 Jul 2008 Omrix Biopharmaceuticals Initiates Phase II Clinical Trial in Israel for Fibrin Pad Product Candidate
01 Jul 2008 Lev Pharmaceuticals to Submit Cinryze(TM) Application to the EMEA
01 Jul 2008 Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
30 Jun 2008 ThromboGenics Announces Positive Results from its Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
30 Jun 2008 Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
30 Jun 2008 Affymax Initiates Clinical Trial of Hematide(TM) to Evaluate Correction of Anemia in Chronic Renal Failure Patients on Dialysis
26 Jun 2008 European approval for Roche's Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment
26 Jun 2008 SciClone and Sigma-Tau Provide Update on Phase 3 Hepatitis C Study
26 Jun 2008 FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
26 Jun 2008 Thallion Receives Health Canada Approval to Initiate Phase II Study for TLN-232 in Metastatic Melanoma Patients
26 Jun 2008 Andromeda Biotech Announces Successful Interim Results of Leading Product DiaPep 227 for Treatment of Type 1 Diabetes Phase III clinical study with DiaPep 277 will continue as planned following the Interim Analysis of Data demonstrating Safety and Efficac
23 Jun 2008 Emisphere Announces License Agreement With Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonists for Diabetes
23 Jun 2008 OVATION Pharmaceuticals To In-License ATryn(R) (antithrombin alfa) in the United States
23 Jun 2008 Jerini to Submit Complete Response to the FDA for Icatibant in the Treatment of HAE
23 Jun 2008 BioGeneriX and Neose Technologies Initiate Phase 2 Trial for GlycoPEG-GCSF
23 Jun 2008 Dyax Announces Final Patient Treated in Second Phase 3 Clinical Trial (EDEMA4(R)) of DX-88 in Hereditary Angioedema
23 Jun 2008 FDA approves Velcade(R) (Bortezomib) for injection for patients with previously untreated multiple myeloma
19 Jun 2008 Eurand Receives Approvable Letter from FDA for EUR-1008 (Zentase(TM))
18 Jun 2008 Nile Therapeutics Completes License Agreement for CU-NP, a Rationally Designed Natriuretic Peptide
18 Jun 2008 Molecular Insight Pharmaceuticals, Inc. Presents Three Studies on Trofex™ Program for Prostate Cancer Diagnosis and Staging
17 Jun 2008 Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008
17 Jun 2008 Gloucester Pharmaceuticals Announces Podium Presentation of Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL
16 Jun 2008 Significant weight loss sustained in obese people treated with liraglutide for one year
16 Jun 2008 Alligator Bioscience AB and PolyTherics Ltd announce strategic collaboration for optimisation of next generation biopharmaceuticals
16 Jun 2008 Pharming Announces Positive Results From North American Randomized Trial With Rhucin(R)
15 Jun 2008 Altus Pharmaceuticals Reports Last Patient Visit Of Trizytek(TM) Phase 3 Efficacy Trial
12 Jun 2008 Lilly and TransPharma Medical Announce Licensing and Development Agreement
11 Jun 2008 Novo Nordisk discontinues phase 3 clinical trial with NovoSeven(R) in trauma
11 Jun 2008 Maxygen Receives Approval for Clinical Trial of Factor VIIa in the United Kingdom
10 Jun 2008 Roche moves investigational diabetes drug, Taspoglutide, into Phase III clinical trials
10 Jun 2008 Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings
10 Jun 2008 Nastech Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting
10 Jun 2008 Targanta submits marketing authorization application for Oritavancin
10 Jun 2008 Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
09 Jun 2008 Study Supports Possible Use Of Leukine(R) As A Potential Adjuvant Therapy For High-Risk Melanoma Patients
09 Jun 2008 Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
09 Jun 2008 XOMA 052 Demonstrates Anti-Inflammatory Effects in Diabetes Animal Studies; Data Presented At ADA
09 Jun 2008 Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
09 Jun 2008 New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
08 Jun 2008 Clinical study shows liraglutide provides statistically significantly better blood glucose control than exenatide
05 Jun 2008 Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
05 Jun 2008 BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome
05 Jun 2008 Pacgen Announces Positive Results from Phase IIb Dose-Ranging Trial of PAC-113
05 Jun 2008 Generex Biotechnology Commences Patient Dosing For Pivotal Phase III Trial of Generex Oral-lyn
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 51 - 100 of 1307

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Emerging Diabetes Drugs

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics